Affiliate, reseller or private label: which model actually fits.

The four models in one paragraph each

The four peptide business models differ mainly in who holds the stock, whose name is on the vial and who the customer belongs to. Everything else follows from those three questions.

• Referral or affiliate

  You send buyers to a supplier and the supplier sells to them directly. You hold no stock and handle no money. In some markets an affiliate earns a commission on each referred sale; whether any arrangement pays at all depends entirely on the supplier.

• Reseller

  You buy stock from a supplier and sell it to your own customers under the supplier's label. You set your own price, run your own customer conversations and carry the stock until it sells. Reseller supply is how this works with Primara.

• Private label

  You sell under your own brand, with the supplier producing labelled runs for you. The vial says your name, the customer thinks of it as your product, and the stock can only be sold by you. Private label covers the supply side.

• Clinic add-on

  An existing clinic, med spa or wellness centre adds peptides to a practice that already has premises, staff and patients. It is less a new business than a line on an existing menu. Clinic and med spa supply covers it.

Capital: how much money each model ties up

Referral ties up almost no capital, reselling ties up as much as the stock you choose to hold, private label ties up the most, and a clinic add-on depends on how much stock the practice holds against its appointment book.

Reselling has a useful middle setting. You can order against confirmed sales, which ties up nothing but means you inherit the supplier's dispatch window on every order, or you can hold stock, which ties up capital but lets you promise faster delivery to your own customers. Most resellers start on the first and move to the second as their run rate settles. How a reseller account works explains the trade-off.

Private label is different in kind, not just in size. A labelled run is committed stock that only you can sell. Under the supplier's label, unsold stock is just stock; under yours, it is stock with no other buyer. That is why private label only makes sense at a volume and consistency you have already proven, and why the realistic first step for most people is not a labelled run at all.

Around the stock there is a cost of being in business that people forget to count: business name registration with the DTI for a sole proprietor, BIR registration and invoicing, an LGU business permit, a dedicated fridge, packaging and the time to run it all. Get your own tax advice on which of these apply to you.

Risk and regulatory exposure

Regulatory exposure rises with how close a model is to putting a product into someone's hands: referral carries the least, reselling more, private label more again, and a clinic administering to patients the most.

The reason is the same in every case. Everything Primara supplies is designated research use only and is not approved for human use in the Philippines. Republic Act 9711, the Food and Drug Administration Act of 2009, governs the registration of health products and the licensing of establishments that distribute or sell them. A business that sells research-use-only compounds for personal or patient use is making its own regulatory decision, and the further along the chain you sit, the more of that decision is yours.

Private label adds a particular exposure: your name is on the vial. When a customer has a question or a complaint, they bring it to the brand, not to the supplier behind it. A clinic adds another: administering anything to a patient sits inside medical practice, which brings in the clinic's own licensing and professional obligations. Get your own legal advice before choosing either.

There is also commercial risk, and it runs the other way. A referrer can lose nothing but the time spent sending buyers. A reseller can be left holding the wrong compound. A private label brand can spend a year selling through a run it guessed at.

Control and who owns the customer

Control and customer ownership increase in step with risk: a referrer owns nothing, a reseller owns the customer relationship, and a private label brand owns the customer and the product identity as well.

In a referral arrangement the buyer orders from the supplier, pays the supplier and talks to the supplier. If the supplier changes its prices, its stock or its policies, the referrer has no say. What the referrer keeps is the trust of the people they sent, which is real but cannot be sold.

A reseller owns the customer conversation, the price and the delivery promise to their own buyers. They do not own the product identity: the vial carries the supplier's label, and a customer who finds the supplier can buy directly. Primara sells direct and supplies resellers, and those overlap; that is stated openly on reseller supply rather than hidden.

A private label brand owns the most, including the product identity. That is the point of private label, and it is also the cost: there is no one behind the brand for a customer to appeal to. Customer data in any model is personal information under the Data Privacy Act of 2012 (Republic Act 10173), and the business holding it carries the obligations that come with it.

Margin potential, in words

Margin potential follows the same ladder: lowest for referral, moderate for reselling, highest per vial for private label, and for a clinic it depends on the service around the product rather than the product itself.

For a reseller, margin is the selling price minus what you paid for the vial, minus courier and packaging you absorb, minus stock that ages before it sells, minus the time spent answering questions. Written as a formula, it is price minus cost of goods minus delivery minus wastage, divided by the hours it took. Most first-time resellers count the first two terms and ignore the rest.

Private label can carry a higher price per vial because the brand is yours, but only once buyers value the brand, which takes time and costs money. Until then the margin is often worse than reselling, because the stock is committed and slower to move.

No figures appear here on purpose. Primara does not publish wholesale tiers, margins or minimums; every public price is on the pack pricing page, and volume terms are set per account on WhatsApp. Pricing peptides for resale covers the arithmetic in more detail.

Workload: what each model asks of you

Referral asks the least work, reselling asks for daily customer service and stock handling, private label adds brand and label management on top, and a clinic add-on asks for process changes inside a practice that already runs.

• Referral

  Sending a link and answering the occasional question with a pointer to the supplier. No stock, no money handling, no deliveries.

• Reseller

  WhatsApp conversations at all hours, payment confirmation by GCash, Maya or bank transfer, booking couriers, storing stock through heat and brownouts, keeping batch records and handling problems. It is a real job.

• Private label

  Everything a reseller does, plus label decisions, a brand presence, trademark questions through the Intellectual Property Office of the Philippines if you want to protect the name, and planning runs further ahead.

• Clinic add-on

  Stock records against treatment records, a dedicated storage unit, staff training and a restock cadence that fits the appointment book. The premises and clients already exist.

Who each model suits

Each model suits a different starting position, and the most common mistake is choosing the model that matches an ambition rather than the one that matches the situation today.

• Referral suits

  Coaches, content creators and community admins who are asked about peptides but should not be handling stock or money, and anyone testing whether there is real demand in their circle.

• Reselling suits

  Someone with a little capital, time to answer messages and a customer base that keeps asking. Become a peptide reseller covers starting out.

• Private label suits

  An established reseller with proven, consistent volume in a few compounds who wants to build something with its own name on it, and who understands the stock commitment.

• Clinic add-on suits

  Existing medical, aesthetic or wellness practices with premises, staff and clients already in place, who are prepared to own their regulatory position.

How to move from one model to the next

The sensible order is referral, then reselling against confirmed sales, then reselling with stock held, then private label, with each step taken only when the previous one has shown real, repeatable demand.

Each step answers a question the next one depends on. Referral shows whether people actually buy. Ordering against confirmed sales shows which compounds move without risking stock. Holding stock shows your real run rate. Only a known run rate tells you whether a labelled run will sell through before it ages.

Moving up costs nothing but the conversation. Moving down is expensive: a private label run that does not sell cannot become reseller stock again. Every kit already ships with blank labels, which is enough for a reseller's own records while the question of a brand is still open.

A clinic add-on is a separate track rather than a step on the ladder. A practice usually goes straight to holding stock against its appointment book, because the clients already exist, and the decision that matters is regulatory rather than commercial.

What Primara offers at each step

Primara Labs supplies every step of that ladder, with terms set per account on WhatsApp and no published tiers, minimums or margins.

For referral, a link carrying a referral code is remembered in the buyer's browser for 30 days and saved with the order so the store knows who referred them. It is a record of who sent the buyer and it does not change the price. Primara does not publish an affiliate or commission programme; ask on WhatsApp whether a referral arrangement fits what you do.

For reselling, every published price including the ten-vial rate is on the pack pricing page, open to anyone, and a reseller account covers volume above a pack, allocation and sourcing outside the catalogue. For private label, custom-labelled runs are something the supply side can do, quoted per run on WhatsApp. For practices, clinic and med spa supply covers restock against an appointment book. Every order at every size ships with bacteriostatic water, syringes, pads, a reconstitution syringe and blank labels, as set out on what ships in the box.